Distribuzione geografica
Continente #
NA - Nord America 11275
EU - Europa 818
AS - Asia 303
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
AF - Africa 2
Totale 12419
Nazione #
US - Stati Uniti d'America 11251
IE - Irlanda 289
IT - Italia 152
CN - Cina 143
KR - Corea 123
DE - Germania 86
UA - Ucraina 81
GB - Regno Unito 49
FR - Francia 39
SE - Svezia 37
BE - Belgio 24
CA - Canada 24
RU - Federazione Russa 23
FI - Finlandia 15
NL - Olanda 7
BR - Brasile 6
JP - Giappone 6
CH - Svizzera 5
EU - Europa 4
PH - Filippine 4
AU - Australia 3
CL - Cile 3
HK - Hong Kong 3
PL - Polonia 3
SG - Singapore 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
DK - Danimarca 2
EG - Egitto 2
IN - India 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AT - Austria 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
SI - Slovenia 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 12419
Città #
Wilmington 3425
Houston 3114
Woodbridge 1695
Fairfield 645
Chandler 460
Cambridge 259
Ashburn 257
Seattle 254
Dublin 247
Ann Arbor 182
Medford 180
Lawrence 86
Rome 78
Dearborn 75
Beijing 73
San Diego 61
Menlo Park 50
Seoul 30
Jacksonville 29
Redwood City 25
Brussels 24
London 23
Norwalk 22
Toronto 18
New York 16
Nanjing 14
Philadelphia 14
Creede 13
Zhengzhou 12
Palo Alto 10
Shanghai 9
San Francisco 7
Atlanta 6
Garden City 6
Mountain View 6
Phoenix 6
Reggio Calabria 5
Shenzhen 5
Verona 5
Wuhan 5
Hefei 4
Huskvarna 4
Kunming 4
Milan 4
Palermo 4
São Paulo 4
Chengdu 3
Helsinki 3
Nashville 3
Redmond 3
Saint Petersburg 3
Santa Clara 3
Singapore 3
Solofra 3
Sutton Coldfield 3
Tokyo 3
Alderley Edge 2
Apeldoorn 2
Augusta 2
Boardman 2
Capranica 2
Changsha 2
Colombo 2
Como 2
Esslingen am Neckar 2
Falls Church 2
Guangzhou 2
Islington 2
Kraków 2
Las Vegas 2
Manila 2
Melbourne 2
Nanchang 2
Naples 2
Porto Alegre 2
San Mateo 2
Thornhill 2
Trumbull 2
Adliswil 1
Almaty 1
Amsterdam 1
Andover 1
Andria 1
Argelato 1
Auckland 1
Bari 1
Bethesda 1
Billings 1
Boydton 1
Budapest 1
Cairo 1
Chicago 1
Colorado Springs 1
Cupertino 1
Dong Ket 1
Dubai 1
Enfield 1
Etobicoke 1
Fiuggi 1
Fremont 1
Totale 11571
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 438
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 436
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 408
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 397
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 380
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 379
Catecholamine-based treatment in AD patients: expectations and delusions 353
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 341
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 331
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 326
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 321
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 318
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 318
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 312
Obstructive sleep apnoea and bone health 306
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 292
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 289
Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity 265
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 254
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 248
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 248
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 238
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study 236
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 234
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 230
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 210
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 202
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 183
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 182
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 168
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 167
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 166
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 166
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 163
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 154
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 153
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 147
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 142
Seasonality of restless legs syndrome: symptom variability in winter and summer times 140
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 137
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 131
Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment 129
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 124
Laterality of Auditory Dysfunction in Parkinson's Disease 115
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 106
Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease 103
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 103
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 97
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 90
Is it time to consider obstructive sleep apnea syndrome a risk factor for Alzheimer's disease? 67
Increased noradrenaline as an additional cerebrospinal fluid biomarker in PSP-like parkinsonism 61
Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure 60
Acute care hospital at different levels of intensity: the role of Geriatrician 56
The reverse metabolic syndrome in the elderly: Is it a “catabolic” syndrome? 55
Multidimensional frailty evaluation in elderly outpatients with chronic heart failure: A prospective study 55
Sarcopenia: Assessment of disease burden and strategies to improve outcomes 51
The Italian version of the “frailty index” based on deficits in health: a validation study 50
Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson's disease: a cerebrospinal fluid-based study 50
Physical Activity Scale for the Elderly (PASE) Score Is Related to Sarcopenia in Noninstitutionalized Older Adults 47
Risk of Malnutrition Evaluated by Mini Nutritional Assessment and Sarcopenia in Noninstitutionalized Elderly People 45
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 41
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 41
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy 40
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 40
Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations 39
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 38
Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect. 38
Sleep problems affect quality of life in Parkinson's disease along disease progression. 38
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients 37
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 31
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 30
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 29
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 29
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 28
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID-19 lockdown 26
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 26
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 25
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 24
Sleep and wake impairment in patients with SARS-CoV2 infection 23
COVID-19: dealing with a potential risk factor for chronic neurological disorders 23
Obstructive sleep apnea, palatal morphology, and aortic dilatation in marfan syndrome growing subjects: A retrospective study 22
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 22
Subthalamic nucleus deep brain stimulation on motor-symptoms of Parkinson's disease: Focus on neurochemistry. 20
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 19
Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up 19
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 15
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 13
The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer's Disease: A Special Focus on Cognitive Performance 13
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 10
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 9
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 7
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases 7
Saliva Analysis of pH and Antioxidant Capacity in Adult Obstructive Sleep Apnea Patients 6
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 4
Totale 12805
Categoria #
all - tutte 21676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21676

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018102 0000 00 00 000102
2018/20191917 82846274 96136 139187 180272304301
2019/20203961 250243188303 276315 296471 521421336341
2020/20213249 373349367358 342387 388298 5914312362
2021/20221112 41654631 1846 21925 518172417
2022/20231210 14211846132 106252 130101 11123490
Totale 12805